Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Benefits of testosterone therapy in men:

Testosterone therapy in men with testosterone deficiency: Are we beyond the point of no return? Traish A et al. Investig Clin Urol. (2016)

Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency. Traish AM et al. Sex Med Rev. (2018)

Testosterone therapy for transgender men. Irwig MS et al. Lancet Diabetes Endocrinol. (2017)

Search results

Items: 1 to 20 of 340

1.

Testosterone replacement therapy is associated with an increased risk of urolithiasis.

McClintock TR, Valovska MI, Kwon NK, Cole AP, Jiang W, Kathrins MN, Bhojani N, Haleblian GE, Koehlmoos T, Haider AH, Basaria S, Trinh QD.

World J Urol. 2019 Mar 23. doi: 10.1007/s00345-019-02726-6. [Epub ahead of print]

PMID:
30903351
2.

Aging and the Male Reproductive System.

Kaufman JM, Lapauw B, Mahmoud A, T'Sjoen G, Huhtaniemi IT.

Endocr Rev. 2019 Mar 19. pii: er.2018-00178. doi: 10.1210/er.2018-00178. [Epub ahead of print]

PMID:
30888401
3.

Late-onset Hypogonadism and Testosterone Therapy - A Summary of Guidelines from the American Urological Association and the European Association of Urology.

Fode M, Salonia A, Minhas S, Burnett AL, Shindel AW.

Eur Urol Focus. 2019 Mar 8. pii: S2405-4569(19)30056-2. doi: 10.1016/j.euf.2019.02.021. [Epub ahead of print]

PMID:
30858073
4.

Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.

Hackett G.

Sex Med Rev. 2019 Feb 22. pii: S2050-0521(18)30147-1. doi: 10.1016/j.sxmr.2018.12.004. [Epub ahead of print] Review.

PMID:
30803918
5.

Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortality.

Saad F, Caliber M, Doros G, Haider KS, Haider A.

Aging Male. 2019 Feb 20:1-12. doi: 10.1080/13685538.2019.1575354. [Epub ahead of print]

PMID:
30782054
6.

Benefits and risks of testosterone therapy in older men.

Cardona Attard C, Fava S.

Minerva Urol Nefrol. 2019 Jan 28. doi: 10.23736/S0393-2249.19.03301-0. [Epub ahead of print]

PMID:
30700083
7.
8.

Effects of testosterone therapy for women: a systematic review and meta-analysis protocol.

Islam RM, Bell RJ, Green S, Davis SR.

Syst Rev. 2019 Jan 11;8(1):19. doi: 10.1186/s13643-019-0941-8.

9.

Do Androgens Modulate the Pathophysiological Pathways of Inflammation? Appraising the Contemporary Evidence.

Traish A, Bolanos J, Nair S, Saad F, Morgentaler A.

J Clin Med. 2018 Dec 14;7(12). pii: E549. doi: 10.3390/jcm7120549. Review.

10.

Withania somnifera (Indian ginseng) in male infertility: An evidence-based systematic review and meta-analysis.

Durg S, Shivaram SB, Bavage S.

Phytomedicine. 2018 Nov 15;50:247-256. doi: 10.1016/j.phymed.2017.11.011. Epub 2017 Nov 29.

PMID:
30466985
11.

Measuring testosterone and testosterone replacement therapy in men receiving androgen deprivation therapy for prostate cancer: A survey of UK uro-oncologists' opinions and practice.

Payne H, McMenemin R, Bahl A, Greene D, Staffurth J.

Int J Clin Pract. 2018 Nov 10:e13292. doi: 10.1111/ijcp.13292. [Epub ahead of print]

PMID:
30414348
12.

What does the research say about androgen use and cerebrovascular events?

Sadaie MR, Farhoudi M, Zamanlu M, Aghamohammadzadeh N, Amouzegar A, Rosenbaum RE, Thomas GA.

Ther Adv Drug Saf. 2018 May 8;9(8):439-455. doi: 10.1177/2042098618773318. eCollection 2018 Aug. Review.

13.

Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors.

Hackett G, Cole N, Mulay A, Strange RC, Ramachandran S.

BJU Int. 2019 Mar;123(3):519-529. doi: 10.1111/bju.14536. Epub 2018 Oct 16.

PMID:
30216622
14.

Long-Term Testosterone Therapy in Type 2 Diabetes Is Associated with Decreasing Waist Circumference and Improving Erectile Function.

Hackett G, Cole N, Mulay A, Strange RC, Ramachandran S.

World J Mens Health. 2018 Sep 12. doi: 10.5534/wjmh.180052M. [Epub ahead of print]

15.

Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations.

Crawford ED, Heidenreich A, Lawrentschuk N, Tombal B, Pompeo ACL, Mendoza-Valdes A, Miller K, Debruyne FMJ, Klotz L.

Prostate Cancer Prostatic Dis. 2019 Mar;22(1):24-38. doi: 10.1038/s41391-018-0079-0. Epub 2018 Aug 21. Review.

16.

Testosterone Replacement Therapy Versus Clomiphene Citrate in the Young Hypogonadal Male.

Scovell JM, Khera M.

Eur Urol Focus. 2018 Apr;4(3):321-323. doi: 10.1016/j.euf.2018.07.033. Epub 2018 Aug 18. Review.

PMID:
30131284
17.

Potential application of testosterone replacement therapy as treatment for obesity and type 2 diabetes in men.

Fink J, Matsumoto M, Tamura Y.

Steroids. 2018 Oct;138:161-166. doi: 10.1016/j.steroids.2018.08.002. Epub 2018 Aug 15. Review.

PMID:
30118780
18.

Type 2 Diabetes and Testosterone Therapy.

Hackett G.

World J Mens Health. 2019 Jan;37(1):31-44. doi: 10.5534/wjmh.180027. Epub 2018 Jul 17. Review.

19.

Impact of Testosterone Deficiency and Testosterone Therapy on Lower Urinary Tract Symptoms in Men with Metabolic Syndrome.

Traish AM, Johansen V.

World J Mens Health. 2018 Sep;36(3):199-222. doi: 10.5534/wjmh.180032. Epub 2018 Jul 3. Review.

20.

To T or not to T: Differences in Testosterone Use and Discontinuation by HIV Serostatus among Men who Have Sex with Men.

Haberlen SA, Jacobson LP, Palella FJ Jr, Dobs A, Plankey M, Lake JE, Kingsley LA, Stall R, Post WS, Brown TT.

HIV Med. 2018 Oct;19(9):634-644. doi: 10.1111/hiv.12644. Epub 2018 Jul 10.

PMID:
29989322

Supplemental Content

Loading ...
Support Center